Summary
Adsorption of cytomegalovirus (CMV) to human fibroblasts was not inhibited by preincubation with other herpes viruses (HSV-1, HSV-2, VZV). Transport of virus to the nucleus was studied using virus labelled with3H-thymidine. Radioactivity was found in the nucleus 20 minutes after virus had been added to the cells. In order to assess the expression of the virus genome, synthesis of early (EA) and late (LA) antigens was studied. Assayed on permissive human lung fibroblasts, a plaque purified virus contained more EA inducing than both EA and LA inducing viral units. Since this was a consistent finding with virions of all densities, it seems to be an effect of viral dose rather than of virion density. Alternatively, LA-defectiveness is a virion property which does not vary with virion density.
Similar content being viewed by others
Reference
Albrecht, T., Rapp, F.: Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virol.55, 53–61 (1973).
Boldogh, I., Gönczöl, E., Gärtner, L., Váczi, L.: Stimulation of host DNA synthesis and induction of early antigens by ultraviolet light irradiated human cytomegalovirus. Arch. Virol.58, 289–299 (1978).
Einhorn, L., Gadler, H., Wahren, B.: Adsorption of purified human cytomegalovirus and induction of early antigens in different cells. J. Med. Virol.10, 225–234 (1982).
Einhorn, L., Steinitz, M., Yefenof, E., Ernberg, I., Bakacs, T., Klein, G.: Epstein-Barr virus (EBV) receptors, complement receptors and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. EBV studies. Cell. Immunol.35, 43–58 (1978).
Einhorn, E., Öst, Å.: Cytomegalovirus infection of human blood cells. J. Inf. Dis. in press (1983).
Eriksson, B., Öberg, B., Wahren, B.: Pyrophosphate analogues as inhibitors of DNA polymerase of cytomegalovirus, herpes simplex virus and cellular origin. Biochim. Biophys. Acta696, 115–123 (1982).
Ernberg, I., Andersson-Anvert, M., Klein, G., Lundin, L., Killander, D.: Relationship between amount of Epstein-Barr virus-determined nuclear antigen per cell and number of EBV-DNA copies per cell. Nature266, 269–271 (1977).
Furukawa, T.: Persistent infection with human cytomegalovirus in a lymphoblastoid cell line. Virology94, 214–218 (1979).
Gadler, H., Wahren, B.: Association between virus and cell DNA during latent cytomegalovirus infectionin vitro. Arch. Virol.75, 291–298 (1983).
Honess, R. W., Roizman, B.: Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol.14, 8–10 (1974).
Jondal, M., Klein, G.: Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors in B lymphocytes. J. Exp. Med.138, 1365–1378 (1973).
Jondal, M., Klein, G., Oldstone, M. B. A., Bokish, V., Yefenof, E.: Association between complement and EBV receptors on human lymphoid cells. Scand. J. Immunol.5, 401–410 (1976).
Martin, M. L., Palmer, E. L., Kissling, R. E.: Complement-fixing antigens of herpes simplex virus types 1 and 2: Reactivity of capsid, envelope, and soluble antigens. Infect. Immun.5, 248–254 (1972).
Mocarski, E. S., Stinski, M. F.: Persistence of the cytomegalovirus genome in human cells. J. Virol.31, 761–775 (1979).
Ramirez, M. L., Virmani, M., Garon, C., Rosenthal, L. J.: Defective virions of human cytomegalovirus. Virol.96, 311–314 (1979).
Rapp, F., Geder, L., Åurasko, D., Lausch, R., Ladda, R., Huang, E. S., Weber, M. M.: Long-term persistence of cytomegalovirus genome in cultured human cells of prostatic origin. J. Virol.16, 982–990 (1975).
Schmitz, H., Doerr, H.-W., Kampa, D., Vogt, A.: Solid-phase enzyme-immunoassay for IgM antibodies to cytomegalovirus. J. Clin. Microbiol.5, 629–634 (1977).
Stinski, M. F., Mocarski, E. S., Thomsen, D. R.: DNA of human cytomegalovirus: Size heterogeneity and defectiveness resulting from serial undiluted passage. J. Virol.31, 231–239 (1979).
Sundqvist, V., Wahren, B.: Antisera to late cytomegalovirus nuclear antigens produced in cynomolgus monkeys. J. Immunol. Meth.40, 307–312 (1981).
Sundqvist, V., Wahren, B.: An interchangeable ELISA for cytomegalovirus antigen and antibody. J. Virol. Meth.2, 301–312 (1981).
Svennerholm, B., Vahlne, A., Lycke, E.: Early interactions of herpes simplex virus with mouse peritoneal macrophages. Infect. Immun.37, 907–911 (1982).
The, T. H., Klein, G., Langenhuysen, M. M. A. C.: Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. Clin. Exp. Immunol.16, 1–12 (1974).
Tocci, M. J., St. Jeor, S. C.: Persistence and replication of the human cytomegalovirus genome in lymphoblastoid cells of B and T origin. Virology96, 664–668 (1979).
Vahlne, A., Svennerholm, B., Lycke, E.: Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes. J. gen. Virol.44, 217–225 (1979).
Wahren, B., Öberg, B.: Inhibition of cytomegalovirus late antigens by phosphonoformate. Intervirol.12, 335–339 (1979).
Wahren, B., Öberg, B.: Reversible inhibition of cytomegalovirus replication by phosphonoformate. Intervirol.14, 7–15 (1980).
Wahren, B., Robèrt, K.-H., Nordlund, S.: Conditions for cytomegalovirus stimulation of lymphocytes. Scand. J. Immunol.13, 581–586 (1981).
Author information
Authors and Affiliations
Additional information
With 3 Figures
Rights and permissions
About this article
Cite this article
Wahren, B., Einhorn, L. & Gadler, H. Early interactions between human cytomegalovirus and cells. Archives of Virology 79, 55–65 (1984). https://doi.org/10.1007/BF01314303
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01314303